Name of organisation
1) Department/Research groupUniversity of Southern Denmark Pharmacoepi center
2) Organisation/affiliationUniversity of Southern Denmark
Short Name in the inventoryUniversity of Southern Denmark Pharmacoepi center
Administrative Contact
Title Professor
Last name Hallas
First name Jesper
Address line 1JB Winsløwsvej 19,2
Address line 2
Address line 3
CityOdense C
PostcodeDK-5000
CountryDenmark
Phone number (incl. country code)45-65503010
Alternative phone number45-60191182
Fax number (incl. country code)45-65916089
Scientific Contact
Title Professor
Last name Hallas
First name Jesper
Address line 1JB Winsløwsvej 19,2
Address line 2
Address line 3
CityOdense C
PostcodeDK-5000
CountryDenmark
Phone number (incl. country code)45-65503010
Alternative phone number45-60191182
Fax number (incl. country code)45-65916089
2. Description
The University of Southern Denmark Pharmcoepi Center is a pharmacoepidemiological research group embedded within the department of clinical pharmacology and pharmacy at the University of Southern Denmark.
The group consists of app 18 persons, including senior epidemiologists, data managers, administrators and PhD students. Its research is focussed on applied, classical pharmacoepidemiology within a wide range of diseases and on method development within fields such as drug utilization research, self-controlled designs and screening of big data for unknown associations.
The group has access to a wide range of nation-wide Danish data sources, including but not limited to the National Prescription Register, the National Patient Register and the Cancer Register. The scientific output is in the order of 70 peer-reviewed papers per year.
3. Category
University based
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
No
Clinician
Yes
No
Clinical Pharmacologist
Yes
No
Pharmacist
Yes
No
Geneticist/Pharmacogeneticist
Yes
No
IT specialist
Yes
No
Ethics expertise
No
Yes
Legal expertise
No
Yes
Regulatory expertise
No
Yes
SoMe expert
Yes
No
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Disorders of the central nervous system
Gastrointestinal tract
Infectious diseases
Malignant disease
Musculoskeletal and joint diseases
Osteoporosis
Respiratory diseases
General practice
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Interventional Clinical Trial
Meta-Analysis
Self-controlled designs
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Between 1500 and 14999
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
Yes
Electronic data capture systems
Yes
System used:
RedCap for example
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
Danish Statistical Institute / Sundhedsdatastyrelsen150
OPED5
11. Registries established by centre
Drug RegistryOPED
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Networks registered with ENCePP
EuroDURG
SIGMA
Other networks:
Network nameNationalInternationalLink to webpage